Thursday, 27 July 2017

AstraZeneca's Mystic lung cancer drug trial falters

AstraZeneca's share price plunged after the drugmaker reported a major setback in trials of a new lung cancer treatment.

from UK News - The latest headlines from the UK | Sky News http://news.sky.com/story/astrazeneca-shares-fall-as-its-mystic-lung-cancer-drug-trial-falters-10963657

No comments:

Post a Comment